Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(17%)
Results Posted
200%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_1
3
50%
Ph phase_2
2
33%
Ph phase_3
1
17%

Phase Distribution

3

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Recruiting1
Terminated1
Completed1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (50.0%)
Phase 22 (33.3%)
Phase 31 (16.7%)

Trials by Status

unknown233%
recruiting117%
terminated117%
completed117%
not_yet_recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
not_yet_recruitingphase_2

A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade

NCT07459166
completedphase_1

Pharmacodynamic Evaluation of Intranasal Nalmefene

NCT04828005
terminatedphase_1

The Effect of Chronic Pain on Delay Discounting in Methadone Patients

NCT04473950
recruitingphase_1

Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists

NCT05338632
unknownphase_2

Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder

NCT03430180
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07459166Phase 2

A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade

Not Yet Recruiting
NCT04828005Phase 1

Pharmacodynamic Evaluation of Intranasal Nalmefene

Completed
NCT04473950Phase 1

The Effect of Chronic Pain on Delay Discounting in Methadone Patients

Terminated
NCT05338632Phase 1

Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists

Recruiting
NCT03430180Phase 2

Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder

Unknown
NCT00020605Phase 3

Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6